The company and its Research & Development activities to tackle antimicrobial resistance, infectious and respiratory disease was highlighted in a recent report by Healthcare UK, a joint initiative of the Department of Health and Social Care, NHS England and the Department for Business and Trade. Healthcare UK champions the UK healthcare sector to foster opportunities and bolster international business growth.
Recent Posts
- NovaBiotics provides a positive clinical data update for its breakthrough toenail health product, Tinexyl® PRO
- NovaBiotics & Liverpool School of Tropical Medicine Collaborate on Cysteamine Bitartrate as a Potential New Intervention in Mycobacterial Disease.
- The Institute of Podiatrists announce endorsement of Tinexyl PRO
- NovaBiotics Pharma Division Highlighted in Healthcare UK report
- NovaBiotics announces move to ONE BioHub
Recent Comments